The Food and Drug Administration approved MedImmune?s FluMist vaccine for children as young as 2, the Gaithersburg company announced Wednesday.
Business is looking up for MedImmune, which was acquired by AstraZeneca in June. Also this year, it won approval for a FluMist formula that doesn?t need to be frozen.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
